(Q28295489)

English

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease

scientific article published on December 1, 2010

In more languages
default values for all languages
No label defined

No description defined

Statements

Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease (English)
0 references
Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease (English)
December 2010
0 references
9
0 references
6
0 references
791-800
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit